Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Bethesda, Maryland
- Most recent report
- 10-Q, filed Jun 24, 2026
- Incorporated
- Nevada
- Filings on record
- 300 filings
- On EDGAR
- CIK 1343009
- Fiscal year ends
- August
- Filer status
- Non-accelerated filer Smaller reporting company Emerging growth company
Financials 8 of 84
News 8 of 81
- 8-K Significant contract Mar 17, 2026
- 8-K Significant contract Jan 30, 2025
- 8-K Current report on a material event Mar 22, 2024
- 8-K Leadership change Feb 8, 2023
- 8-K Leadership change Dec 29, 2022
- 8-K Leadership change Jul 25, 2022
- 8-K Current report on a material event May 13, 2022
- 8-K Other events Mar 28, 2022
Prospectuses and Registrations 8 of 17
- S-1 Registration statement for an offering Feb 18, 2022
- S-1 Registration statement for an offering May 10, 2021
- S-1/A Registration statement for an offering, amended Feb 23, 2021
- S-1 Registration statement for an offering Jan 27, 2021
- 424B5 Prospectus supplement for an offering Sep 26, 2018
- 424B2 Prospectus supplement for an offering Sep 12, 2018
- 424B2 Prospectus supplement for an offering Aug 21, 2018
- 424B2 Prospectus supplement for an offering Jun 1, 2018
Ownership 8 of 38
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 8, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Feb 5, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 10, 2025
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 13, 2025
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 13, 2025
- SCHEDULE 13G/A Large holder reported a passive stake, amended Feb 13, 2025
- SC 13G/A Large holder reported a passive stake, amended Nov 14, 2024
Other 8 of 80
- UPLOAD Comment letter from SEC staff Jun 17, 2024
- CORRESP Reply to SEC staff Jun 6, 2024
- UPLOAD Comment letter from SEC staff May 30, 2024
- CORRESP Reply to SEC staff May 21, 2024
- UPLOAD Comment letter from SEC staff Apr 22, 2024
- NT 10-Q Notice that a quarterly report will be late Apr 15, 2024
- CORRESP Reply to SEC staff Apr 10, 2024
- UPLOAD Comment letter from SEC staff Jan 29, 2024
Everything here comes from CNBX Pharmaceuticals Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.